Jenny Humphreys Arthritis Research UK Clinical Research Fellow University of Manchester

Size: px
Start display at page:

Download "Jenny Humphreys Arthritis Research UK Clinical Research Fellow University of Manchester"

Transcription

1 Incidence of rheumatoid arthritis in the UK using the 2010 ACR/EULAR classification criteria; and comparison with estimates using the 1987 ACR criteria Jenny Humphreys Arthritis Research UK Clinical Research Fellow University of Manchester

2 Disclosure This speaker has no conflicts of interest

3 Background Classification criteria essential

4 The ACR 1987 revised criteria for the classification of rheumatoid arthritis 1 Criterion Definition A patient is classified as RA if 4/7 criteria are satisfied. Criteria 1-4 must have been present for 6 weeks 1. Morning stiffness Morning stiffness in and around the joints, lasting at least an hour before maximal improvement 2. Arthritis of 3 joints 3 joints simultaneously have had synovitis observed ay a physician 3. Arthritis of hand joints At least 1 area swollen in a wrist, MCP or PIP joint 4. Symmetric arthritis Simultaneous involvement of the same joint areas on both sides of the body 5. Rheumatoid nodules Subcutaneous nodules, over bony prominences, extensor surfaces or juxta-articular regions 6. Serum RF Positive RF 7. Radiographic changes Radiographic changes typical of RA in posteroanterior hand and wrist radiographs 1. Arnett FC et al 1988

5 Background Classification criteria essential 1987 ACR criteria: Poor sensitivity in early disease Importance of early treatment

6 Background Classification criteria essential 1987 ACR criteria: Poor sensitivity in early disease Importance of early treatment New therapies untested in early disease

7 2010 ACR/EULAR Classification Criteria for RA 2 Target population: Patients who (i) have at least one joint with clinical synovitis, and (ii) with the synovitis not better explained by another disease Score Add score of categories A-D, score of 6/10 needed to classify patient as having definite RA A. Joint involvement (tender/swollen) 1 large joint 2-10 large joints 1-3 small joints (with or without involvement of large joints) 4-10 small joints (with or without involvement of large joints) >10 joints (at least 1 small joint) B. Serology Negative RF&ACPA Low-positive RF/low positive ACPA High positive RF/high-positive ACPA C. Acute-phase reactants Normal CRP&ESR Abnormal CRP/ESR 0 1 D. Duration of symptoms <6 weeks 6 weeks Aleteha D et al 2010

8 Background New definition new disease? What is the disease frequency?

9 Study questions What is the incidence of RA in the UK as estimated by the 2010 classification criteria? How does this compared to estimates using 1987 classification criteria? How do the criteria sets perform cumulatively?

10 Setting: Norfolk Arthritis Register (NOAR) Primary care inception cohort Adults 16 2 swollen joints 4 weeks

11 Primary care based NOAR - Strengths Stable population Mix of urban and rural Single referral point for musculoskeletal medicine

12 Incidence Incidence rate (IR) = Number of new cases of disease in specified time period Total population

13 Methods Patients with disease onset 1990 Presented to NOAR within 5 years symptom onset Denominator: Norwich health authority population 1991 census Assessments at baseline,1, 2, 3 & 5 years Both criteria sets applied at baseline & cumulatively over 5 years follow up

14 Recruitment and follow-up Baseline: Nurse led interview Demographics Symptom duration Joint examination (DAS28) HAQ Blood tests CRP, RF and ACPA Follow-up: Nurse led interview & examination HAQ Year 5: Blood test (CRP, RF & ACPA) X-rays

15 Cumulative IRs 2010 criteria: Total of highest scores for each parameter over 5 years follow up

16 2010 ACR/EULAR Classification Criteria for RA Target population: Patients who (i) have at least one joint with clinical synovitis, and (ii) with the synovitis not better explained by another disease Score Add score of categories A-D, score of 6/10 needed to classify patient as having definite RA A. Joint involvement (tender/swollen) 1 large joint 2-10 large joints 1-3 small joints (with or without involvement of large joints) 4-10 small joints (with or without involvement of large joints) >10 joints (at least 1 small joint) B. Serology Negative RF&ACPA Low-positive RF/low positive ACPA High positive RF/high-positive ACPA C. Acute-phase reactants Normal CRP&ESR Abnormal CRP/ESR 0 1 D. Duration of symptoms <6 weeks 6 weeks 0 1

17 Cumulative IRs 2010 criteria: Total of highest scores for each parameter over 5 years follow up 1987 criteria Criterion carried forward once satisfied

18 The ACR 1987 revised criteria for the classification of rheumatoid arthritis Criterion Definition A patient is classified as RA if 4/7 criteria are satisfied. Criteria 1-4 must have been present for 6 weeks 1. Morning stiffness Morning stiffness in and around the joints, lasting at least an hour before maximal improvement 2. Arthritis of 3 joints 3 joints simultaneously have had synovitis observed ay a physician 3. Arthritis of hand joints At least 1 area swollen in a wrist, MCP or PIP joint 4. Symmetric arthritis Simultaneous involvement of the same joint areas on both sides of the body 5. Rheumatoid nodules Subcutaneous nodules, over bony prominences, extensor surfaces or juxta-articular regions 6. Serum RF Positive RF 7. Radiographic changes Radiographic changes typical of RA in posteroanterior hand and wrist radiographs

19 Results

20 Baseline characteristics n=260 Age at symptom onset mean (std dev) 54 (16.2) Female n (%) 173 (69%) Symptom duration in weeks median (IQ range) 29.6 ( ) RF/ACPA positive 82 (35%) Acute phase reactant positive n (%) 120 (52%) Morning stiffness 60 mins n (%) 172 (66%) Rheumatoid nodules n (%) 19 (7%)

21 Baseline characteristics n=260 Joint involvement: n (%) 1 large joint 9 (3%) 2-10 large joints 9 (3%) 1-3 small joints 41 (16%) 4-10 small joints 52 (20%) >10 joints 149 (57%) Arthritis of 3 joints n (%) 172 (66%) Arthritis of hand joints n (%) 215 (83%) Symmetric arthritis n (%) 183 (70%)

22 Per population Baseline incidence rates (IRs)

23 Per population Baseline incidence rates (IRs) (women) 1987 (women) 2010 (men)1987 (men)

24 Per population Baseline 2010 age specific IRs (women) Age (10 yr groupings)

25 Per population Baseline 2010 & 5 year cumulative 1987 IRs (women) Age (10 yr groupings)

26 Per population Baseline 2010 age specific IRs (men) Age (10 yr groupings)

27 Per population Baseline 2010 & 5 year cumulative 1987 IRs (men) Age (10 yr groupings)

28 HOWEVER...

29 Criteria overlap Patients who satisfy 2010 criteria at baseline Patients who satisfy 1987 criteria cumulatively at 5 years n = 22 n = 35 n =145

30 Criteria overlap Patients who satisfy 2010 criteria at baseline Patients who satisfy 1987 criteria cumulatively at 5 years n = 22 n = 35 n =145 n = 58

31 Conclusions The first study to estimate incidence rates using the 2010 criteria The 2010 criteria classify more patients at initial presentation Similar rates at baseline that previous criteria take up to 5 years classify not the same patients Future work

32 Professor Deborah Acknowledgements Symmons Dr Kimme Hyrich Dr Suzanne Verstappen NOAR research nurses NOAR patients Arthritis Research UK Epidemiology Unit team

33

Dr Sarah Levy Consultant Rheumatology Croydon University Hospital

Dr Sarah Levy Consultant Rheumatology Croydon University Hospital Dr Sarah Levy Consultant Rheumatology Croydon University Hospital Contents Definition/ epidemiology Diagnosis Importance of early diagnosis/ treatment Guidelines Evidence based treatment protocol Current

More information

2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis

2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis 2010 ACR/EULAR Classification Criteria for Rheumatoid Arthritis Published in the September 2010 Issues of A&Rand ARD Phases of the Project Phase 1 Data analysis Phase 2 Consensus process Predictors of

More information

Early identification and treatment - the Norwegian perspective. Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway

Early identification and treatment - the Norwegian perspective. Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway Early identification and treatment - the Norwegian perspective Till Uhlig Dept of Rheumatology Diakonhjemmet Hospital Oslo, Norway Oslo Rheumatoid Arthritis Registry (ORAR) Very early Arthritis Clinic

More information

Rheumatoid Arthritis. Nicole Klett,, M.D.

Rheumatoid Arthritis. Nicole Klett,, M.D. Rheumatoid Arthritis Nicole Klett,, M.D. Rheumatoid Arthritis Systemic Chronic Inflammatory Primarily targets the synovium of diarthrodial joints Etiology likely combination genetic and environmental Diarthrodial

More information

Early Diagnosis of Rheumatoid Arthritis & Axial Spondyloarthritis

Early Diagnosis of Rheumatoid Arthritis & Axial Spondyloarthritis Early Diagnosis of Rheumatoid Arthritis & Axial Spondyloarthritis 奇 美 醫 院 過 敏 免 疫 風 濕 科 陳 宏 安 Rheumatoid arthritis Most common chronic inflammatory joint disease Multisystem autoimmune disease of unknown

More information

Evolution of Classification Criteria for Rheumatoid Arthritis: How Do the 2010 Criteria Perform?

Evolution of Classification Criteria for Rheumatoid Arthritis: How Do the 2010 Criteria Perform? Evolution of Classification Criteria for Rheumatoid Arthritis: How Do the 2010 Criteria Perform? Elizabeth C. Ortiz, MD*, Shuntaro Shinada, MD KEYWORDS Rheumatoid arthritis Classification criteria Inflammatory

More information

Rheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P. 2015 Frontiers in Medicine

Rheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P. 2015 Frontiers in Medicine Rheumatology Labs for Primary Care Providers Robert Monger, M.D., F.A.C.P. 2015 Frontiers in Medicine Objectives Review the Indications for and Interpretation of lab testing for the following diseases:

More information

Measuring and Improving the Quality of Care for Patients With. Rheumatoid Arthritis

Measuring and Improving the Quality of Care for Patients With. Rheumatoid Arthritis Measuring and Improving the Quality of Care for Patients With Rheumatoid Arthritis section 1 reporting Measuring and Improving the Quality of Care for Patients With Rheumatoid Arthritis An estimated 1.3

More information

Rheumatoid arthritis: an overview. Christine Pham MD

Rheumatoid arthritis: an overview. Christine Pham MD Rheumatoid arthritis: an overview Christine Pham MD RA prevalence Chronic inflammatory disease affecting approximately 0.5 1% of the general population Prevalence is higher in North America (approaching

More information

I. INCLUSION AND EXCLUSION CRITERIA

I. INCLUSION AND EXCLUSION CRITERIA Page 1 of 5 I. INCLUSION AND EXCLUSION CRITERIA INCLUSION CRITERIA Yes No 1. Patient is diagnosed with according to the American College of Rheumatology 1987 revised criteria. 2. All 4 grandparents are

More information

DISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY

DISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY ORIGINAL ARTICLES DISEASE COURSE IN EARLY RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY Teodora Serban 1,2, Iulia Satulu 2, Oana Vutcanu 2, Mihaela Milicescu 1,2, Carina Mihai 1,2, Mihai Bojinca 1,2, Victor

More information

Symptoms ongoing for 6/12, initially intermittent in nature.

Symptoms ongoing for 6/12, initially intermittent in nature. Rheumatoid Arthritis Case Study INTRODUCTION Each student will have watched the relevant MDT member carrying out their initial assessment on the same newly diagnosed Rheumatoid Arthritis patient. Videos

More information

New Evidence reports on presentations given at EULAR 2012. Rituximab for the Treatment of Rheumatoid Arthritis

New Evidence reports on presentations given at EULAR 2012. Rituximab for the Treatment of Rheumatoid Arthritis New Evidence reports on presentations given at EULAR 2012 Rituximab for the Treatment of Rheumatoid Arthritis Report on EULAR 2012 presentations Long-term safety of rituximab: 10-year follow-up in the

More information

Early Rehabilitation of Rheumatoid Arthritis (RA)

Early Rehabilitation of Rheumatoid Arthritis (RA) Early Rehabilitation of Rheumatoid Arthritis (RA) Results and Hands-On Experiences with the Implementation of a Randomized Controlled Trial in Health Services Research Susanne Schlademann University of

More information

How does Vectra DA measure my RA disease activity? What is Vectra DA? The more you and your doctor know about your RA, the better you can manage it

How does Vectra DA measure my RA disease activity? What is Vectra DA? The more you and your doctor know about your RA, the better you can manage it KNOW YOUR RA SCORE 65 58 50 42 40 35 29 21 15 The advanced blood test that helps you and your doctor better understand your rheumatoid arthritis (RA) disease activity with a single score 1 What is Vectra

More information

Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy

Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy R Adams 1, Ct Ng 2, A Gibbs 2, L Tilson 1, D Veale 2, B Bresnihan 2, O FitzGerald 2, M Barry 1 1. National Centre for

More information

Clinically Actionable Biomarkers in Rheumatoid Arthritis

Clinically Actionable Biomarkers in Rheumatoid Arthritis Clinically Actionable Biomarkers in Rheumatoid Arthritis PepTalk January 6, 2009 William Robinson, MD, PhD Stanford University School of Medicine VA Palo Alto Health Care System T cell mediated Autoimmune

More information

(Intro to Arthritis with a. Arthritis) Manager of Education & Services for the Vancouver Island Region of The Arthritis Society

(Intro to Arthritis with a. Arthritis) Manager of Education & Services for the Vancouver Island Region of The Arthritis Society Arthritis 101 (Intro to Arthritis with a Focus on Rheumatoid Arthritis) by Cari Taylor by Cari Taylor Manager of Education & Services for the Vancouver Island Region of The Arthritis Society What You Will

More information

Evaluation of Disorders of the Hands and Wrists

Evaluation of Disorders of the Hands and Wrists Evaluation of Disorders of the Hands and Wrists Case 27 yo female with 6 month history of right forearm and hand pain Works as secretary, symptoms are interfering with her job duties Complains that she

More information

Arthritis of the Hands

Arthritis of the Hands Arthritis of the Hands On the Agenda Normal Osteoarthitis Rheumatoid arthritis CPPD crystal deposition Gout Psoriatic arthritis Normal Hand X-ray Osteoarthritis (DJD) Gradual degeneration of articular

More information

Psoriatic arthritis in practice : How to detect? How to diagnose? Pascal RICHETTE Hôpital Lariboisière, Paris. Copyright

Psoriatic arthritis in practice : How to detect? How to diagnose? Pascal RICHETTE Hôpital Lariboisière, Paris. Copyright Psoriatic arthritis in practice : How to detect? How to diagnose? Pascal RICHETTE Hôpital Lariboisière, Paris The patient: a 57 year-old man, with a history of psoriatic nail dystrophy for 10 years Past

More information

Predictors of Physical Therapy Use in Patients with Rheumatoid Arthritis

Predictors of Physical Therapy Use in Patients with Rheumatoid Arthritis Predictors of Physical Therapy Use in Patients with Rheumatoid Arthritis Maura Iversen,, PT, DPT, SD, MPH 1,2,3 Ritu Chhabriya,, MSPT 4 Nancy Shadick, MD 2,3 1 Department of Physical Therapy, Northeastern

More information

Rheumatoid Arthritis www.arthritis.org.nz

Rheumatoid Arthritis www.arthritis.org.nz Rheumatoid Arthritis www.arthritis.org.nz Did you know? RA is the second most common form of arthritis Approximately 40,000 New Zealanders have RA RA can occur at any age, but most often appears between

More information

How To Treat Ankylosing Spondylitis

How To Treat Ankylosing Spondylitis Inflammatory Arthritis and Biologic therapy Ministry of Health(MOH) Recommendations Biologic Therapy for Inflammatory Arthritis Ministry of Health Recommendations Introduction Chronic inflammatory arthropathies

More information

A patientwithsystemicsclerosis andjointpain. Christian Beyer University Erlangen-Nuremberg(GER)

A patientwithsystemicsclerosis andjointpain. Christian Beyer University Erlangen-Nuremberg(GER) A patientwithsystemicsclerosis andjointpain Christian Beyer University Erlangen-Nuremberg(GER) Whatisimportanttoyou? lungs GI tract fatigue heart skin muscles Raynaud s joints Whatisimportanttopatients?

More information

Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-ray Erosion Detection

Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-ray Erosion Detection Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-ray Erosion Detection Michael Tomizza, BSc, MSc Candidate October 15, 2014: Hamilton

More information

NURS 821 Alterations in the Musculoskeletal System. Rheumatoid Arthritis. Type III Hypersensitivity Response

NURS 821 Alterations in the Musculoskeletal System. Rheumatoid Arthritis. Type III Hypersensitivity Response NURS 821 Alterations in the Musculoskeletal System Margaret H. Birney PhD, RN Lecture 12 Part 2 Joint Disorders (cont d) Rheumatoid Arthritis Definition: Autoimmune disorder occurring in genetically sensitive

More information

Rheumatoid Arthritis: Constantly Evolving Treatment Approaches

Rheumatoid Arthritis: Constantly Evolving Treatment Approaches Rheumatoid Arthritis: Constantly Evolving Treatment Approaches Jody Garry, Pharm.D. Primary Care Pharmacy Resident VA Medical Center - Iowa City Presentation Overview Pathophysiology & epidemiology Diagnostic

More information

Linking biobanks to registries: Why and how? Anne Barton

Linking biobanks to registries: Why and how? Anne Barton Linking biobanks to registries: Why and how? Anne Barton Biobanks why should we collect samples? Anti-TNF treatment in RA Cost approx. 8,000/person/year 30-40% RA patients do not respond Rare, serious

More information

Rheumatoid Arthritis

Rheumatoid Arthritis Rheumatoid Arthritis Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic inflammation of the joints. Autoimmune diseases are illnesses that occur when the body's tissues are mistakenly

More information

DIVISION OF RHEUMATOLOGY DEPARTMENT OF MEDICINE UNIVERSITY OF WESTERN ONTARIO POSTGRADUATE EDUCTION ORTHOPAEDIC OFF-SERVICE GOALS & OBJECTIVES

DIVISION OF RHEUMATOLOGY DEPARTMENT OF MEDICINE UNIVERSITY OF WESTERN ONTARIO POSTGRADUATE EDUCTION ORTHOPAEDIC OFF-SERVICE GOALS & OBJECTIVES DIVISION OF RHEUMATOLOGY DEPARTMENT OF MEDICINE UNIVERSITY OF WESTERN ONTARIO POSTGRADUATE EDUCTION ORTHOPAEDIC OFF-SERVICE GOALS & OBJECTIVES GOAL #1 develop the ability to order and understand interpretation

More information

SYNOPSIS. 2-Year (0.5 DB + 1.5 OL) Addendum to Clinical Study Report

SYNOPSIS. 2-Year (0.5 DB + 1.5 OL) Addendum to Clinical Study Report Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Abatacept () Name of Active Ingredient: Abatacept () Individual Study Table Referring to the Dossier (For National Authority Use

More information

Psoriasis, Incidence, Quality of Life, Psoriatic Arthritis, Prevalence

Psoriasis, Incidence, Quality of Life, Psoriatic Arthritis, Prevalence 1.0 Abstract Title Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients with Psoriasis Severe or Moderate with Adalimumab Treatment (TOGETHER). Keywords Psoriasis,

More information

Rheumatic Fever Vs. (?) Post Strep Reactive Arthritis ינואר 2009

Rheumatic Fever Vs. (?) Post Strep Reactive Arthritis ינואר 2009 Rheumatic Fever Vs. (?) Post Strep Reactive Arthritis ינואר 2009 Agenda Introduction Articles Poststreptococcal reactive arthritis in children: is it really a different entity from rheumatic fever? Poststreptococcal

More information

Rheumatoid Arthritis. Osama khataybeh

Rheumatoid Arthritis. Osama khataybeh Rheumatoid Arthritis Osama khataybeh Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease of unknown cause. An external trigger (eg, cigarette smoking, infection, or trauma) that triggers

More information

Services for people with rheumatoid arthritis

Services for people with rheumatoid arthritis Services for people with rheumatoid arthritis INTERNATIONAL COMPARISONS International comparisons 1 In this paper, the National Audit Office has reviewed published literature about rheumatoid arthritis

More information

Treatment of Severe Rheumatoid Arthritis

Treatment of Severe Rheumatoid Arthritis Treatment of Severe Rheumatoid Arthritis Zhanguo Li Department of Rheumatology and Immunology, People s Hospital Beijing University Medical School, China Contents Background Challenges Treatment strategies

More information

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background: 1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance

More information

Rheumatoid Arthritis:

Rheumatoid Arthritis: Rheumatoid Arthritis Update 2014 Mark Hulsey, MD FACR Rheumatoid Arthritis Key Features Symptoms >6 weeks duration Often lasts the remainder of the patient s life Inflammatory synovitis Palpable synovial

More information

Integra. MCP Joint Replacement PATIENT INFORMATION

Integra. MCP Joint Replacement PATIENT INFORMATION Integra MCP Joint Replacement PATIENT INFORMATION Integra MCP Patient Information This brochure summarizes information about the use, risks, and benefits of the Integra MCP finger implant. Be sure to discuss

More information

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe

Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Developing a National Audit for Rheumatoid and Early Inflammatory Arthritis Ian Rowe Chair Clinical Affairs Committee, BSR Outline The British Society for Rheumatology Challenges in improving patient outcomes

More information

Evaluating the ENAT : reconciling findings from a mixed methods study

Evaluating the ENAT : reconciling findings from a mixed methods study School of Healthcare FACULTY OF MEDICINE AND HEALTH Evaluating the ENAT : reconciling findings from a mixed methods study Professor Claire A Hale School of Healthcare University of Leeds On behalf of the

More information

Aspects of disability in rheumatoid arthritis - a five-year follow-up in the Swedish TIRA project

Aspects of disability in rheumatoid arthritis - a five-year follow-up in the Swedish TIRA project Linköping University Medical Dissertations No. 1063 Aspects of disability in rheumatoid arthritis - a five-year follow-up in the Swedish TIRA project Mathilda Björk Rehabilitation Medicine, Department

More information

Media Release. Basel, 11 June 2009. RA patients with enhanced response identified

Media Release. Basel, 11 June 2009. RA patients with enhanced response identified Media Release Basel, 11 June 2009 New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis RA patients

More information

National Rheumatoid Arthritis Society

National Rheumatoid Arthritis Society National Rheumatoid Arthritis Society METHODOLOGY NOTE ComRes interviewed,0 GB adults online from the 0 th to the th April 0. Data were weighted to be demographically representative of all GB adults aged

More information

Understanding Rheumatoid Arthritis

Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis Understanding Rheumatoid Arthritis What Is Rheumatoid Arthritis? 1,2 Rheumatoid arthritis (RA) is a chronic autoimmune disease. It causes joints to swell and can result

More information

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 17 December 2003 CPMP/EWP/556/95 rev 1/Final COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

More information

Development and Validation of a Screening Questionnaire for Psoriatic Arthritis

Development and Validation of a Screening Questionnaire for Psoriatic Arthritis Development and Validation of a Screening Questionnaire for Psoriatic Arthritis Dafna D. Gladman 1, Catherine T. Schentag 1, Brian D. Tom 2, Vinod Chandran 1, Cheryl F. Rosen 1 Vernon T. Farewell 2 1 University

More information

It is worth noting that people with psoriasis can also develop other forms of arthritis such as rheumatoid arthritis and osteoarthritis.

It is worth noting that people with psoriasis can also develop other forms of arthritis such as rheumatoid arthritis and osteoarthritis. Psoriatic Arthritis Main Colour - pantone 2597u Research - pantone 206u Children - pantone 123 4 What is psoriatic arthritis? Psoriatic arthritis is an inflammatory joint disease associated with psoriasis.

More information

DAS28 criteria for initiation of biologics in early RA: a clinician s view. Dr Patrick Kiely St George s Healthcare NHS Trust, London

DAS28 criteria for initiation of biologics in early RA: a clinician s view. Dr Patrick Kiely St George s Healthcare NHS Trust, London DAS28 criteria for initiation of biologics in early RA: a clinician s view Dr Patrick Kiely St George s Healthcare NHS Trust, London History: NICE (E&W) guidelines for starting anti-tnf agents April 2001

More information

RHEUMATOID ARTHRITIS-PRESENTATION AND OUTCOME OF MANAGEMENT

RHEUMATOID ARTHRITIS-PRESENTATION AND OUTCOME OF MANAGEMENT Original Article -PRESENTATION AND OUTCOME OF MANAGEMENT 1 Muhammad Kaleem Shaukat, 2 Noor Akbar Sial, 3 Muhammad Abrar 1 Assistant Professor Orthopaedics, University Medical College, Faisalabad. 2 Assistant

More information

Arthritis Research UK Epidemiology Unit

Arthritis Research UK Epidemiology Unit Arthritis Research UK Epidemiology Unit Qualitative research proposal to explore factors influencing acceptable risk thresholds used to recommend particular treatment options for rheumatoid arthritis.

More information

A patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis

A patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis A patient and public guide to the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis 1st Annual Report 2015 (Data collection: 1 February 2014 30 April 2015) 2 Contents Background Who

More information

Rheumatoid Arthritis

Rheumatoid Arthritis Rheumatoid Arthritis While rheumatoid arthritis (RA) has long been feared as one of the most disabling types of arthritis, the outlook has dramatically improved for many newly diagnosed patients. Certainly

More information

Rheumatoid Arthritis. Outline. Treatment Goal 4/10/2013. Clinical evaluation New treatment options Future research Discussion

Rheumatoid Arthritis. Outline. Treatment Goal 4/10/2013. Clinical evaluation New treatment options Future research Discussion Rheumatoid Arthritis Robert L. Talbert, Pharm.D., FCCP, BCPS University of Texas at Austin College of Pharmacy University of Texas Health Science Center at San Antonio Outline Clinical evaluation New treatment

More information

Etanercept (Enbrel ) in Patients with Rheumatoid Arthritis with Recent Onset Versus Established Disease: Improvement in Disability

Etanercept (Enbrel ) in Patients with Rheumatoid Arthritis with Recent Onset Versus Established Disease: Improvement in Disability Etanercept (Enbrel ) in Patients with Rheumatoid Arthritis with Recent Onset Versus Established Disease: Improvement in Disability SCOTT W. BAUMGARTNER, ROY M. FLEISCHMANN, LARRY W. MORELAND, MICHAEL H.

More information

Am I likely to develop. rheumatoid Arthritis? A guide for people with joint symptoms

Am I likely to develop. rheumatoid Arthritis? A guide for people with joint symptoms Am I likely to develop Rheumatoid rheumatoid Arthritis? arthritis? A guide for people with joint symptoms At a glance Rheumatoid arthritis (RA) is a common disease that causes painful and swollen joints,

More information

Defining Remission in Rheumatoid Arthritis

Defining Remission in Rheumatoid Arthritis Defining Remission in Rheumatoid Arthritis Part 1: Why is a new remission definition in rheumatoid arthritis needed? Background Increasing numbers of patients reach remission Abundance of remission definitions

More information

Test Request Tip Sheet

Test Request Tip Sheet With/Without Contrast CT, MRI Studies should NOT be ordered simultaneously as dual studies (i.e., with and without contrast). Radiation exposure is doubled and both views are rarely necessary. The study

More information

ABOUT RHEUMATOID ARTHRITIS

ABOUT RHEUMATOID ARTHRITIS MEDIA BACKGROUNDER ABOUT RHEUMATOID ARTHRITIS Rheumatoid arthritis (RA) is a type of arthritis (chronic inflammatory polyarthritis) that typically affects hands and feet, although any joint in the body

More information

MANUAL OSTEOPATHY JOINT MOBILIZATION FOR TREATMENT OF RHEUMATOID ARTHRITIS

MANUAL OSTEOPATHY JOINT MOBILIZATION FOR TREATMENT OF RHEUMATOID ARTHRITIS MANUAL OSTEOPATHY JOINT MOBILIZATION FOR TREATMENT OF RHEUMATOID ARTHRITIS Student; Liu Ai Cao, RMT Investigative Project as required by National Academy of Osteopathy June 2011 Professor: Dr. Shahin Pourgol,

More information

Overview of Rheumatology

Overview of Rheumatology Overview of Rheumatology Griffin Hospital Mini Med School Stephen Moses, MD Valley Medical Associates 135 Division St. Ansonia, CT 06401 203.735.9354 Topics I. Anatomy of a Joint II. Osteoarthritis III.

More information

British Journal of Rheumatology 1996;35:1101-1105

British Journal of Rheumatology 1996;35:1101-1105 British Journal of Rheumatology 1996;35:1101-1105 REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE

More information

2012 Rheumatoid Arthritis Update

2012 Rheumatoid Arthritis Update For your information Clinical Professor of Medicine, David Geffen School of Medicine at UCLA Private practice, Tustin CA 2012 Rheumatoid Arthritis Update Robin K. Dore, MD Clinical Professor of Medicine

More information

Rheumatoid Arthritis

Rheumatoid Arthritis Rheumatoid Arthritis Module I Clinical Features and Diagnosis Dr Ved Chaturvedi MD, DM Senior Consultant Rheumatologist, Army Medical Corps President, Indian Rheumatology Association Dr Vinod Ravindran

More information

Treat to Target Approach in Rheumatoid Arthritis: UK perspective. Dr Deirdre Shawe, North Hampshire Hospital, Basingstoke, UK

Treat to Target Approach in Rheumatoid Arthritis: UK perspective. Dr Deirdre Shawe, North Hampshire Hospital, Basingstoke, UK Treat to Target Approach in Rheumatoid Arthritis: UK perspective Dr Deirdre Shawe, North Hampshire Hospital, Basingstoke, UK What is the target? To achieve remission or low disease activity in Rheumatoid

More information

Roche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy

Roche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy Media Release Basel, 6 June 2012 Roche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced

More information

Predicting The Risk Of Rheumatoid Arthritis

Predicting The Risk Of Rheumatoid Arthritis Predicting The Risk Of Rheumatoid Arthritis Modelling Genetic And Environmental Risk Factors Ian Scott Arthritis Research UK Clinical Research Fellow Declaration Of Interests: No Competing Interests Describe

More information

Rheumatoid Arthritis: Key Features

Rheumatoid Arthritis: Key Features Rheumatoid Arthritis: Key Features Symptoms >6 weeks duration Often lasts the remainder of the patient s life Inflammatory synovitis Palpable synovial swelling Morning stiffness >1 hour, fatigue Symmetrical

More information

EXERCISE 5: ERYTHROCYTES SEDIMENTATION RATE - ESR, SED RATE

EXERCISE 5: ERYTHROCYTES SEDIMENTATION RATE - ESR, SED RATE EXERCISE 5: ERYTHROCYTES SEDIMENTATION RATE - ESR, SED RATE Textbook: Skills: None 10 points Objectives: 1. State the principle of the Erythrocytes Sedimentation Rate - ESR. 2. List two factors which may

More information

TREG EULAR Conference Analysis. Rome, Italy June 16-19, 2010

TREG EULAR Conference Analysis. Rome, Italy June 16-19, 2010 TREG EULAR Conference Analysis Rome, Italy June 16-19, 21 Rheumatoid Arthritis: Management and Current Therapies Arthur Kavanaugh, MD Martin Bergman, MD John J Cush, MD Orrin Troum, MD Alvin Wells MD,

More information

Ultrasound For Rheumatologists: Focus on Hands and Feet

Ultrasound For Rheumatologists: Focus on Hands and Feet THE RHEUMATISM SOCIETY OF THE DISTRICT OF COLUMBIA PRESENTS Ultrasound For Rheumatologists: Focus on Hands and Feet September 12, 2015 2730 University Boulevard West Westfield North Building 7th Floor

More information

A Survey of Barriers to Treatment Access in Rheumatoid Arthritis. Country Annex Report: UK

A Survey of Barriers to Treatment Access in Rheumatoid Arthritis. Country Annex Report: UK A Survey of Barriers to Treatment Access in Rheumatoid Arthritis Country Annex Report: UK October 2009 1 Interviews In the UK, five rheumatologists and one patient representative were interviewed. The

More information

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Harvard-MIT Division of Health Sciences and Technology HST.021: Musculoskeletal Pathophysiology, IAP 2006 Course Director: Dr. Dwight R. Robinson Systemic Lupus Erythematosus A multi-system autoimmune

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT European Medicines Agency Evaluation of Medicines for Human Use London, 23 June 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS

More information

Autoimmune Diseases More common than you think Randall Stevens, MD

Autoimmune Diseases More common than you think Randall Stevens, MD Autoimmune Diseases More common than you think Randall Stevens, MD picture placeholder Autoimmune Diseases More than 60 different disorders Autoimmune disorders (AID) diseases caused by the immune system

More information

Normal Range. Reference Values. Types of Reference Ranges. Reference Range Study. Reference Values

Normal Range. Reference Values. Types of Reference Ranges. Reference Range Study. Reference Values Advanced Laboratory Medicine Post-Analytic Issues: Reference Ranges and Interpretation Daniel J. Fink, MD, MPH Director, Core Laboratory New York Presbyterian Hospital Columbia University Medical Center

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency London, 14 December 2006 Doc. Ref. CHMP/EWP/438/04 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT

More information

ACT-RAY and MRI substudy

ACT-RAY and MRI substudy Tocilizumab as Monotherapy or in Combination With Methotrexate associated with Early Reductions in Tissue Inflammation: 12-Week Results From a Magnetic Resonance Imaging Substudy of a Randomized Controlled

More information

Evidence-based Management of Rheumatoid Arthritis (2009)

Evidence-based Management of Rheumatoid Arthritis (2009) CPLD reviews its distance learning programmes every twelve months to ensure currency. This update has been produced by an expert and should be read in conjunction with the Evidencebased Management of distance

More information

RHEUMATOID ARTHRITIS. Dr Bruce Kirkham Rheumatology Clinical Lead

RHEUMATOID ARTHRITIS. Dr Bruce Kirkham Rheumatology Clinical Lead RHEUMATOID ARTHRITIS Dr Bruce Kirkham Rheumatology Clinical Lead RHEUMATOID ARTHRITIS (RA) RA is a common disease: 0.8 per cent of the population RA more common in females: female to male ratio 3:1 RA

More information

Prognostic factors in rheumatoid arthritis

Prognostic factors in rheumatoid arthritis Prognostic factors in rheumatoid arthritis Thesis Éva Palkonyai M.D. Semmelweis University, Budapest School of Ph.D. Studies Supervisor: Péter Gergely MD, D.Sci Budapest 2006. 1 Contents 1. Introduction

More information

Psoriatic Arthritis. Title. Understanding and Managing. in All the Wrong Places. Clinical Features. Etiology of Psoriatic Arthritis

Psoriatic Arthritis. Title. Understanding and Managing. in All the Wrong Places. Clinical Features. Etiology of Psoriatic Arthritis Focus on CME at Memorial University Understanding and Managing Title Psoriatic Arthritis in All the Wrong Places Proton Rahman MD, MSc, FRCPC Although Baron Jean-Luis Aubert offered the first case description

More information

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Jeffrey Sparks Brigham and Women's Hospital Harvard Medical School USA 25-Nov-2015

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW. Jeffrey Sparks Brigham and Women's Hospital Harvard Medical School USA 25-Nov-2015 PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)

More information

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND EPIDEMIOLOGY OF HEPATITIS B IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 11 References 12 Epidemiology of Hepatitis

More information

Testosterone Treatment in Older Men

Testosterone Treatment in Older Men Testosterone Treatment in Older Men J. Bruce Redmon, M.D. Professor Division of Endocrinology Departments of Medicine and Urologic Surgery Disclosure Information I have no financial relationships to disclose.

More information

Gene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga Rakidzich

Gene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga Rakidzich TITLE Effect of daily use natural astaxanthin on C-reactive protein. Conducted by: Health Research & Studies Center, Los Altos, CA Gene A. Spiller, PhD, Antonella Dewell, MS, RD, Sally Chaves, RN, Zaga

More information

The Vectra DA Test for Rheumatoid Arthritis

The Vectra DA Test for Rheumatoid Arthritis Medical Policy Manual Topic: Vectra DA Blood Test for Rheumatoid Arthritis Date of Origin: June 2014 Section: Laboratory Last Reviewed Date: May 2015 Policy No: 67 Effective Date: July 1, 2015 IMPORTANT

More information

Rheumatoid Arthritis. Disease RA Final.indd 2 15. 6. 10. 11:23

Rheumatoid Arthritis. Disease RA Final.indd 2 15. 6. 10. 11:23 Rheumatoid Arthritis Disease RA Final.indd 2 15. 6. 10. 11:23 Understanding what to expect can help you prepare for your transition into treatment. Rheumatoid Arthritis What You Need To Know About Rheumatoid

More information

Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Brochure More information from http://www.researchandmarkets.com/reports/3128342/ Methotrexate (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Description: Methotrexate (Rheumatoid Arthritis)

More information

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE ACTIVITY DESCRIPTION Rheumatoid arthritis (RA) is an inflammatory type of

More information

ACR and EULAR Improvement Criteria Have Comparable Validity in Rheumatoid Arthritis Trials

ACR and EULAR Improvement Criteria Have Comparable Validity in Rheumatoid Arthritis Trials ACR and EULAR Improvement Criteria Have Comparable Validity in Rheumatoid Arthritis Trials ANKE M. van GESTEL, JENNIFER J. ANDERSON, PIET L.C.M. van RIEL, MAARTEN BOERS, CEES J. HAAGSMA, BILL RICH, GEORGE

More information

How will we prevent rheumatoid arthritis? Kevin Deane, MD/PhD Division of Rheumatology University of Colorado

How will we prevent rheumatoid arthritis? Kevin Deane, MD/PhD Division of Rheumatology University of Colorado How will we prevent rheumatoid arthritis? Kevin Deane, MD/PhD Division of Rheumatology University of Colorado Outline 1) Brief overview of natural history of RA and how current understanding of disease

More information

Recognise, Respond, Relieve, Rheumatoid Arthritis

Recognise, Respond, Relieve, Rheumatoid Arthritis Recognise, Respond, Relieve, Rheumatoid Arthritis Anybody can develop rheumatoid arthritis. It can develop at any age in adults but is more common in people in their 40s and 50s. It is two to three times

More information

Back & Neck Pain Survival Guide

Back & Neck Pain Survival Guide Back & Neck Pain Survival Guide www.kleinpeterpt.com Zachary - 225-658-7751 Baton Rouge - 225-768-7676 Kleinpeter Physical Therapy - Spine Care Program Finally! A Proven Assessment & Treatment Program

More information

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.

More information

Arthritis & Rheumatism

Arthritis & Rheumatism ARTHRITIS & RHEUMATISM Vol. 62, No. 9, September 2010, pp 2569 2581 DOI 10.1002/art.27584 2010, American College of Rheumatology Arthritis & Rheumatism An Official Journal of the American College of Rheumatology

More information

Disease Activity and Remission in Rheumatoid Arthritis

Disease Activity and Remission in Rheumatoid Arthritis KUOPION YLIOPISTON JULKAISUJA D. LÄÄKETIEDE 441 KUOPIO UNIVERSITY PUBLICATIONS D. MEDICAL SCIENCES 441 HEIDI MÄKINEN Disease Activity and Remission in Rheumatoid Arthritis Comparison of Available Disease

More information

Top 10 Title issues in Rheumatoid. Arthritis. Rheumatoid arthritis (RA) is a chronic inflammatory. in All the Wrong Places

Top 10 Title issues in Rheumatoid. Arthritis. Rheumatoid arthritis (RA) is a chronic inflammatory. in All the Wrong Places Focus on CME at the University of British Columbia Top 10 Title issues in Rheumatoid in All the Wrong Places Arthritis By John Wade, MD; and John R. Watterson, MD Case 1 A young woman presents with an

More information

3 Rd Year Medical Student Lecture Series. Rheumatology Cases. N. Lawrence Edwards, MD

3 Rd Year Medical Student Lecture Series. Rheumatology Cases. N. Lawrence Edwards, MD 3 Rd Year Medical Student Lecture Series Rheumatology Cases N. Lawrence Edwards, MD Case Study #1 32 yo WF accountant with 6 months of bilat finger and wrist pain and swelling. Morning stiffness involving

More information